Bandaram Pharma Packtech Share Price

  • 34.50-1.95 (-5.34%)
  • Volume: 2,321
BSE
  • Closed
  • Last Updated On: 08 Sep, 2025, 03:31 PM IST
Loading...
Bandaram Pharma Packtech Share Price
  • 34.50-1.95 (-5.34%)
  • Volume: 2,321
Advertisment

Bandaram Pharma Pack share price insights

  • Company has spent 1.66% of its operating revenues towards interest expenses and 8.0% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

  • Bandaram Pharma Packtech Ltd. share price moved down by -5.34% from its previous close of Rs 36.45. Bandaram Pharma Packtech Ltd. stock last traded price is 34.50

    Share PriceValue
    Today/Current/Last-34.50
    Previous Day-36.45

InsightsBandaram Pharma Pack

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    49.98
    EPS - TTM
    (₹)
    0.69
    MCap
    (₹ Cr.)
    41.40
    Sectoral MCap Rank
    41
    PB Ratio
    (x)
    2.77
    Div Yield
    (%)
    0.00
    Face Value
    (₹)
    10.00
    Beta

    Beta

    1 Month-
    3 Months-0.22
    6 Months-0.04
    1 Year-0.01
    3 Years-0.03

    -
    VWAP
    (₹)
    35.28
    52W H/L
    (₹)
    63.14 / 31.00

    Bandaram Pharma Pack Share Price Returns

    1 Day-5.34%
    1 Week7.81%
    1 Month-9.07%
    3 Months-9.19%
    1 Year-23.08%
    3 YearsN.A.
    5 YearsN.A.

    ET Stock ScreenersTop Score Companies

    Check whether Bandaram Pharma Pack belongs to analysts' top-rated companies list?

    View Stock Screeners

    Bandaram Pharma Pack Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Bandaram Pharma Pack Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Bandaram Pharma Pack Financials

    • Insights

      • Employee & Interest Expense

        Company has spent 1.66% of its operating revenues towards interest expenses and 8.0% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
      Quarterly | AnnualJun 2025Mar 2025Dec 2024Sep 2024Jun 2024
      Total Income8.108.5910.007.1111.37
      Total Income Growth (%)-5.61-14.1340.65-37.46-15.60
      Total Expenses7.618.489.496.1810.98
      Total Expenses Growth (%)-10.33-10.6353.70-43.73-14.90
      EBIT0.500.100.500.930.39
      EBIT Growth (%)390.79-80.00-45.82138.40-31.46
      Profit after Tax (PAT)0.010.15-0.010.670.18
      PAT Growth (%)-90.95--101.10276.84-5.71
      EBIT Margin (%)6.121.185.0513.113.44
      Net Profit Margin (%)0.171.75-0.079.451.57
      Basic EPS (₹)0.010.13-0.010.560.15
      Quarterly | AnnualJun 2025Mar 2025Dec 2024Sep 2024Jun 2024
      Total Income0.763.802.633.172.72
      Total Income Growth (%)-80.0844.52-16.8916.3478.76
      Total Expenses1.033.752.582.842.97
      Total Expenses Growth (%)-72.6244.97-8.84-4.5494.11
      EBIT-0.270.060.050.33-0.25
      EBIT Growth (%)-576.9120.04-85.82--
      Profit after Tax (PAT)-0.270.040.010.33-0.25
      PAT Growth (%)-722.97193.20-95.56--
      EBIT Margin (%)-35.451.481.7810.45-9.13
      Net Profit Margin (%)-35.451.130.5610.45-9.13
      Basic EPS (₹)-0.220.040.010.28-0.21
      Quarterly | Annual FY 2025 FY 2024
      Total Revenue37.0634.11
      Total Revenue Growth (%)8.6480.28
      Total Expenses35.7432.93
      Total Expenses Growth (%)8.5577.05
      Profit after Tax (PAT)0.990.52
      PAT Growth (%)90.68267.82
      Operating Profit Margin (%)5.216.22
      Net Profit Margin (%)2.681.52
      Basic EPS (₹)0.830.81
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue12.3214.8710.09--
      Total Revenue Growth (%)-17.1147.28---
      Total Expenses12.1414.699.820.010.03
      Total Expenses Growth (%)-17.4149.620.01-67.91-97.28
      Profit after Tax (PAT)0.140.130.20-0.01-0.03
      PAT Growth (%)9.03-37.12---
      Operating Profit Margin (%)1.511.152.700.000.00
      Net Profit Margin (%)1.140.862.020.000.00
      Basic EPS (₹)0.120.110.68-1.44-0.01

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2025 FY 2024
      Total Assets38.9232.06
      Total Assets Growth (%)21.4058.90
      Total Liabilities23.1016.99
      Total Liabilities Growth (%)35.9412.96
      Total Equity15.8215.07
      Total Equity Growth (%)5.00193.51
      Current Ratio (x)2.202.13
      Total Debt to Equity (x)1.360.99
      Contingent Liabilities0.00-
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets19.2113.368.273.001.26
      Total Assets Growth (%)43.7961.55175.67138.10-5.97
      Total Liabilities7.111.155.190.013.58
      Total Liabilities Growth (%)518.26-77.840.01-99.7214.74
      Total Equity12.1012.203.072.99-2.32
      Total Equity Growth (%)-0.82297.392.68--
      Current Ratio (x)3.488.3110.45299.990.66
      Total Debt to Equity (x)0.290.001.430.00-0.63
      Contingent Liabilities0.0010.17---

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2025 FY 2024
      Net Cash flow from Operating Activities-4.93-4.13
      Net Cash used in Investing Activities-0.08-1.58
      Net Cash flow from Financing Activities5.095.59
      Net Cash Flow0.08-0.11
      Closing Cash & Cash Equivalent0.120.04
      Closing Cash & Cash Equivalent Growth (%)181.95-
      Total Debt/ CFO (x)-3.48-2.95
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities-3.25-3.23-3.872.91-
      Net Cash used in Investing Activities0.00-1.40-2.53-1.55-
      Net Cash flow from Financing Activities3.234.614.400.72-
      Net Cash Flow-0.02-0.02-2.002.08-
      Closing Cash & Cash Equivalent0.020.070.092.08-
      Closing Cash & Cash Equivalent Growth (%)-73.17-23.00-95.910.010.00
      Total Debt/ CFO (x)-1.07-0.01-1.140.00-

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2025 FY 2024
      Return on Equity (%)7.854.24
      Return on Capital Employed (%)7.7510.69
      Return on Assets (%)2.551.62
      Interest Coverage Ratio (x)4.763.05
      Asset Turnover Ratio (x)1.041.30
      Price to Earnings (x)56.1885.47
      Price to Book (x)4.403.62
      EV/EBITDA (x)26.0120.85
      EBITDA Margin (%)7.888.36
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)1.151.056.64-0.330.00
      Return on Capital Employed (%)1.181.403.64-0.33-31.13
      Return on Assets (%)0.720.962.46-0.33-2.50
      Interest Coverage Ratio (x)955.000.00548.80-69.640.00
      Asset Turnover Ratio (x)0.751.371.79--
      Price to Earnings (x)400.00357.14107.53-454.55-105.26
      Price to Book (x)4.603.647.121.45-1.42
      EV/EBITDA (x)309.48238.2195.50-226.67-358.76
      EBITDA Margin (%)1.561.252.710.000.00

    Financial InsightsBandaram Pharma Pack

    • Income (P&L)
      • Employee & Interest Expense

        Company has spent 1.66% of its operating revenues towards interest expenses and 8.0% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Bandaram Pharma Pack Technicals

    • Stock doesn't have any Buy/Sell Signals.

    • Price Analysis Data details are not available.

    • Pivot Levels

      R1R2R3PIVOTS1S2S3
      Classic-------

      Average True Range

      5 DAYS14 DAYS28 DAYS
      ATR---

    Bandaram Pharma Pack Peer Comparison

    Peers InsightsBandaram Pharma Pack

      Do you find these insights useful?

      • hate it

      • meh

      • love it

      Bandaram Pharma Pack Shareholding Pattern

      • Loading...
        Showing Bandaram Pharma Pack Shareholding as on Jun 2025
        CategoryJun 2025Mar 2025Dec 2024Sep 2024
        Promoters75.0075.0075.0075.00
        Pledge0.000.000.000.00
        FII0.000.000.000.00
        DII0.000.000.000.00
        Mutual Funds0.000.000.000.00
        Others25.0025.0025.0025.00
      • Showing Shareholding as on Jun 2025
        CategoryNo. of SharesPercentage% Change QoQ
        Promoters90,00,00075.00 %0.00
        Pledge00.00 %0.00
        Others30,00,00025.00 %0.00

      Bandaram Pharma Pack MF Ownership

      MF Ownership details are not available.

      Bandaram Pharma Pack Corporate Actions

      • Meeting DateAnnounced onPurposeDetails
        Aug 14, 2025Aug 08, 2025Board MeetingQuarterly Results
        Jul 21, 2025Jun 27, 2025EGM-
        Jun 20, 2025Jun 16, 2025Board MeetingPreferential Issue of shares & Others
        May 30, 2025May 22, 2025Board MeetingAudited Results
        Mar 14, 2025Feb 20, 2025EGM-
      • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
        Final1%0.1Sep 20, 2024Sep 04, 2024
      • All TypesEx-DateRecord DateAnnounced onDetails
        RightsJun 30, 2023Jun 30, 2023Feb 07, 2023Rights ratio: 3 share for every 1 held at a price of Rs 10.0

      About Bandaram Pharma Pack

      Bandaram Pharma Packtech Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 43.74 Crore) operating in Hospitals & Allied Services sector. Bandaram Pharma Packtech Ltd. key Products/Revenue Segments include Recycled Paper for the year ending 31-Mar-2024. Show More

      • Executives

      • Auditors

      • BD

        B Deepak Reddy

        Chairman & Managing Director
        BP

        B Premsai Reddy

        Non Executive Director
        BS

        B Sathyavathi

        Non Executive Director
        BS

        B Suryaprakasa Rao

        Independent Director
        Show More
      • M M Reddy & Co.
        Srinivas P & Associates

      FAQs about Bandaram Pharma Pack share

      • 1. What's Bandaram Pharma Pack share price today and what are Bandaram Pharma Pack share returns ?
        Bandaram Pharma Pack share price is Rs 34.50 as on 08 Sep, 2025, 03:31 PM IST. Bandaram Pharma Pack share price is down by 5.34% based on previous share price of Rs 34.5. Bandaram Pharma Pack share price trend:
        • Last 3 Months: Bandaram Pharma Pack share price moved down by 9.19%
        • Last 12 Months: Bandaram Pharma Pack share price moved down 23.08%
        • Last 3 Years: Bandaram Pharma Pack Share price moved remain unchanged by N.A.
      • 2. What is Bandaram Pharma Pack's 52 week high / low?
        In last 52 weeks Bandaram Pharma Pack share had a high price of Rs 63.14 and low price of Rs 31.00
      • 3. What is the PE & PB ratio of Bandaram Pharma Pack?
        The PE ratio of Bandaram Pharma Pack stands at 52.81, while the PB ratio is 2.76.
      • 4. What are the returns for Bandaram Pharma Pack share?
        Return Performance of Bandaram Pharma Pack Shares:
        • 1 Week: Bandaram Pharma Pack share price moved up by 7.81%
        • 3 Month: Bandaram Pharma Pack share price moved down by 9.19%
        • 6 Month: Bandaram Pharma Pack share price moved down by 27.67%
      • 5. What's the market capitalization of Bandaram Pharma Pack?
        Within the Hospitals & Allied Services sector, Bandaram Pharma Pack stock has a market cap rank of 41. Bandaram Pharma Pack has a market cap of Rs 41.40 Cr.

      Trending in Markets

      Top Gainers As on 03:59 PM | 08 Sep 2025

      Suven Pharma 1,012.95
      90.06 (9.76%)
      Guj Mineral Dev.539.15
      30.15 (5.93%)
      Bharat Forge1,202.80
      66.10 (5.82%)
      Ashok Leyland137.29
      6.52 (4.99%)
      JP Power20.02
      0.95 (4.99%)

      Top Losers As on 03:57 PM | 08 Sep 2025

      Amber Enterprises7,473.00
      -320.50 (-4.12%)
      EID Parry1,067.30
      -45.50 (-4.09%)
      Trent5,315.50
      -213.00 (-3.86%)
      Godfrey Philips10,657.00
      -416.00 (-3.76%)
      Coromandel Int.2,185.20
      -72.71 (-3.22%)

      DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

      DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

      By using this site, you agree to the Terms of Service and Privacy Policy.

      The Economic Times